In 2026, Anvisa joined Brazil’s government mission to China to strengthen cooperation on health products, including medicines, medical devices, and blood products. The mission focuses on regulatory alignment, technology transfer, and sharing of technical knowledge. Director Daniela Marreco officially represents Anvisa, engaging with Chinese authorities, companies, and smart hospitals. This collaboration aims to streamline product registration while maintaining safety and quality, enabling faster access to advanced medical technologies in Brazil.
In March 2026, Anvisa joined the Brazilian government delegation visiting China to strengthen bilateral cooperation on health products. Led by Director Daniela Marreco, the mission focuses on regulatory alignment, technology transfer to Brazil, and high-quality production of medicines, medical devices, and blood products. The initiative aims to make the registration process more efficient, ensuring safe, high-quality medical technologies reach the Brazilian market faster.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us